fbpx

Dr. Hester, Be Medispa Receive the 2017 Presidential Associate Award from Galderma

fullsizerender-2Owner of Be Medispa, in Lexington Kentucky, Dr. Paul Hester was awarded the 2017 Galderma Presidential Associate Award for leading trends in aesthetic injectables. There’s good reason that cosmetic filler injections targeting patients’ biggest aging concerns—from lines and wrinkles to volume loss—are a favorite nonsurgical cosmetic option among women and men. Today’s improved formulations of hyaluronic acid and other fillers have resulted in longer lasting, more targeted products that can, in the span of a lunchtime office visit, rejuvenate aging patients’ faces.

Dr. Hester says he and his wife Chasity, PA use the spectrum of fillers daily in the Lexington practice. “We are humbled to receive such an honorable award presented by Galderma.  These collagen fillers have improved drastically in the past few years leaving longer lasting, natural results, which is what we strive for every day in our practice. We have experienced tremendous growth in the number of injectable treatments. We are a results driven practice, providing an unmatched experience with real and relevant results. These products have laid the foundation to make it possible.” Dr. Hester says.

Galderma offers a broad spectrum of filler options, each tailored to a specific cosmetic result. Restylane Silk, Lyft, Refyne and Defyne are suited to correct and restore volume loss in the face while maintaining a natural expression.

Be Medispa and their expert staff offer state-of-the-art advanced procedures in laser and nonsurgical cosmetic and aesthetic skin care. In addition to all advanced treatments, Be Medispa offers physician designed skin care products for home use. Be Medispa is sought out by patients from around the country for expertise and innovation in cosmetic treatments performed by Dr. Hester.

Be Medispa is located at 812 E. High Street Lexington, KY, 40502; 161 Lexington Green Cir, Lexington, KY 40503 Tel: (859) 266-5483.



© All Rights Reserved, Company BeMedispa 2024